ArticleJPRAS open2026
Perioperative blood pressure and hematoma risk after gender-affirming mastectomy.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hematoma formation is a common complication following gender-affirming mastectomy, yet the contribution of perioperative hemodynamics to hematoma risk in this population remains unclear. Methods: A retrospective cohort study was performed of transgender patients undergoing bilateral gender-affirming mastectomy by a single surgeon from 2016 to 2023. Hematoma was defined as a postoperative collection requiring surgical evacuation. MAP was calculated at baseline, preoperatively, intraoperatively, and within one hour postoperatively. Group comparisons and multivariable logistic regression were used to assess predictors of hematoma formation. Results: Among 216 patients, 8 (3.7%) developed hematomas requiring evacuation. Patients who developed hematoma had significantly lower intraoperative MAP than those without hematoma (73.5 ± 7.2 vs. 83.9 ± 8.6 mmHg, p = 0.004). In addition, the increase in MAP from the intraoperative to postoperative period was significantly greater in the hematoma group (25.6 ± 15.0 vs. 5.85 ± 12.6 mmHg, p = 0.007). On multivariable logistic regression, the intraoperative-to-postoperative MAP increase was a strong independent predictor of hematoma formation (OR 1.14 per mmHg increase, p < 0.001). Conclusion: Optimizing perioperative hemodynamic stability may be an important modifiable factor in reducing hematoma formation and improving outcomes after gender-affirming top surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.